Dren Bio: Clinical Trials

7 trials sponsored by Dren Bio, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting, 1 available. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 2, Recruiting 2, Active not recruiting 1, Not yet recruiting 1
Phase 22Not yet recruiting 1, Recruiting 1

Follow Dren Bio: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
Dibotatug (DR-01) - Bone Marrow Failure Syndromes, Aplastic Anemias
Phase 1 / Phase 2Not yet recruitingDren Bio602026-08-012026-07-24
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
DR-0202 - Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1RecruitingDren Bio962025-06-032026-01-07
A Study of Subcutaneous DR-01 in Healthy Volunteers
DR-01, Placebo - Healthy Volunteer
Phase 1CompletedDren Bio322025-03-032025-09-29
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
DR-01 - Alopecia Areata, Vitiligo
Phase 1Active not recruitingDren Bio812024-10-302026-07-08
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers
DR-0201, Placebo - Healthy Adult Volunteers
Phase 1CompletedDren Bio102023-11-262024-08-13
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
DR-01 - LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous Gamma-Delta T-Cell Lymphoma
Phase 1 / Phase 2RecruitingDren Bio2002022-07-132026-06-17
Availability of Dibotatug (DR-01) Outside Clinical Trials Via Expanded Access for Eligible Participants
Dibotatug
AvailableDren Bio2026-06-15

Conditions studied

Alopecia (1)  ·  Alopecia Areata (1)  ·  Anemia, Aplastic (1)  ·  Bone Marrow Failure Disorders (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Transitional Cell (1)  ·  Endometrial Neoplasms (1)  ·  Enteropathy-Associated T-Cell Lymphoma (1)  ·  Hair Diseases (1)  ·  Hematologic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Large Granular Lymphocytic (1)  ·  Leukocyte Disorders (1)  ·  Lymphoma (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)

Countries

United States (4)  ·  Australia (3)  ·  New Zealand (2)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Michael Rothenberg, MD, PhD (2)  ·  Wan-Jen Hong, MD (2)  ·  Matthias Will, MD (1)  ·  Wan Jen Hong, MD (1)